QUCYHealthcare · Diagnostics & Research

QUCY Stock Forecast: Quantum Cyber NV Price Predictions for 2026-2027

Last close, 31 July 2026

$1.14

Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 4 of 100 as at 1 Aug 2026 — in the weakest quartile.

Market cap

$26.0M

Ticker Nerd rank

4 / 100

Median analyst target

—

Analysts covering

Ticker Nerd rank

QUCY stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Quantum Cyber NV on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 1 Aug 2026

4 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Size

Momentum

Revisions

Volatility

Issuance

Accruals

Growth

Quality

Value

Size (86): Smaller than most of the companies we track.

Value (1): The shares cost a lot relative to the profits and assets behind them.

The rank is the raw material. Whether the rules would actually own Quantum Cyber NV — and when they’d sell — is the membership.

Wall Street

QUCY stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on QUCY, reported as data — targets and ratings, the market's view beside the model's.

We don’t hold enough price history for this company yet.

What Wall Street says1 analysts

0 Buy1 Hold0 Sell

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Estimates

QUCY analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year

Analysts raising

Analysts cutting

Fundamentals

Quantum Cyber NV (QUCY) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation

Trailing P/E: −0.4×
Price / sales: 48.3×
Price / book: 3.1×
EV / EBITDA: −1.0×

Growth & margins

Revenue growth (YoY): −100.0%
Earnings growth (YoY): —
Gross margin: —
Operating margin: −2460.8%
Net margin: 72.6%

Returns & dividend

Return on equity: −300.9%
Return on assets: −94.3%
Dividend yield: —

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

QUCY vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelDiagnostics & Research

Company	Market cap	TKN rank
QUCYQuantum Cyber NV	$26.0M	4
PRPOPrecipio, Inc.	$37.9M	50
ADVBAdvanced Biomed, Inc.	$13.2M	10
XWELXWELL, Inc.	$8.3M	47
MBAICheck-Cap Ltd.	$7.4M	8
XGNExagen, Inc.	$109.0M	44
FRNMFreenome, Inc.	$115.0M	50

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. QUCY appears on the weeks it earns a place.

News

Latest QUCY news & analysis

StreetWatch: As Federal Funding Floods the Drone Market, Quantum Cyber Is Assembling a Next Generation Platform

Newsfile Corp · 3 Aug 2026positive

Washington is accelerating its drone strategy on two fronts: directing significant capital into domestic production and targeting supply chains behind Iranian UAVs. Quantum Cyber N.V. is reported to be assembling a next-generation platform amid this shift.

Why it matters — A QUCY watcher would care because federal drone-sector funding and supply-chain policy could create a larger market context for Quantum Cyber's next-generation platform development.

Quantum Cyber Applauds President Trump's Drone Dominance Program and Supply Chain Framework, Reaffirms Commitment to On-Shore U.S. Manufacturing of Autonomous Systems

GlobeNewsWire · 29 July 2026positive

Quantum Cyber NV issued a statement congratulating President Trump and applauding his Drone Dominance Program and Supply Chain Framework, while reaffirming the company's commitment to on-shore U.S. manufacturing of autonomous systems.

Why it matters — The statement signals QUCY's alignment with federal policy priorities that could directly affect its business in drone warfare, counter-UAS, and border security markets.

Quantum Cyber Completes First Mini-Interceptor Drone at Its Newly U.S. Manufacturing Facility in Bridgeport, Connecticut

GlobeNewsWire · 27 July 2026positive

Quantum Cyber completed its first mini-interceptor drone airframe at its newly acquired approximately 50,000 square foot manufacturing facility in Bridgeport, Connecticut, with an 80-unit 3D printing drone production farm expected to come online shortly.

Why it matters — This marks the first physical output from the company's Interceptor Product Line at its new U.S. facility, signaling a move from facility acquisition into actual production.

FAQ

Frequently asked questions about QUCY stock

Is QUCY stock a buy right now?

Of the 1 analysts covering Quantum Cyber NV, 0 rate it a Buy, 1 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Quantum Cyber NV 4 out of 100 across roughly 4,600 US stocks as at 1 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank QUCY?

As at 1 Aug 2026, Quantum Cyber NV ranks 4 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Size (86 of 100).

What is the QUCY stock forecast for 2030?

No analyst covering Quantum Cyber NV publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for QUCY are extrapolating price history, which says nothing about the business.

What does Quantum Cyber NV do?

What is the latest news on QUCY?

The most recent item we track (Newsfile Corp, 3 Aug 2026): "StreetWatch: As Federal Funding Floods the Drone Market, Quantum Cyber Is Assembling a Next Generation Platform". Washington is accelerating its drone strategy on two fronts: directing significant capital into domestic production and targeting supply chains behind Iranian UAVs. Quantum Cyber N.V. is reported to be assembling a next-generation platform amid this shift.

Company

About Quantum Cyber NV.

Mainz Biomed N.V. is a molecular genetics diagnostic company specializing in the development of market-ready solutions for the early detection of life-threatening conditions, particularly colorectal and pancreatic cancers. Its flagship product, ColoAlert, is a non-invasive genetic test that outperforms the standard fecal immunochemical test (FIT) in detecting colorectal tumors by analyzing specific genetic markers in stool samples, enabling earlier intervention and better patient outcomes. The company is also advancing proprietary genetic testing methods for pancreatic cancer screening, addressing one of the most challenging areas in oncology diagnostics. Mainz Biomed N.V. focuses on creating simple, affordable, and reliable tools that empower healthcare providers and patients with accessible early detection options, manufactured to high standards including DIN EN ISO 13485 certification. Operating from Mainz, Germany, in a hub for advanced DNA and pharmaceutical research, the company contributes to the biotechnology sector by prioritizing innovative, cost-effective diagnostics that support preventive healthcare strategies worldwide. Founded in 2008, Mainz Biomed N.V. remains dedicated to genetic and genomic testing tailored to individual disease profiles.

CEO Mr. David Elliot Lazar · 10 employees · Germany · https://quantum-cyber.ai